| Expression pattern: |
DS |
| Associated gene: |
RBPs |
| Associated microRNA: |
- |
| Biological function: |
Associated with cisplatin drug sensitivity (cisplatin resistance) in lung cancer cells; related to translation regulation |
| Molecular mechanism: |
Likely involved in RBPs-mediated biological processes rather than miRNA sponge (not accumulated in AGO2 pellet); predicted circEIF3as/RBPs interaction network; low coding potential |
| Biological pathway or process: |
drug resistance (other); other pathway/process (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; RIP (RNA Immunoprecipitation); Transfection; CCK8; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
- |
| Description: |
hsa_circ_0092857 is differentially expressed between A549 and cisplatin-resistant A549/DDP lung cancer cells. Its downregulation alters cisplatin resistance, and the study suggests an RBP-related mechanism connected to translation regulation with little evidence for AGO2/miRNA-sponge activity. |
| Confidence score: |
0.6579 |